Carisma Therapeutics Inc (CARM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 0 | 0 | 425 | 29,981 | 990 |
| Gross Profit | N/A | N/A | 425 | 29,981 | 990 |
| Operating Expenses | 108,491 | 34,500 | 29,680 | 27,115 | 36,186 |
| Operating Income | -108,491 | -34,500 | -29,255 | 2,866 | -35,196 |
| Interest Expense | 0 | 0 | 0 | 247 | 1,395 |
| Other Income | 991 | 807 | 226 | -723 | 3,139 |
| Pre-tax Income | -107,500 | -33,693 | -29,029 | 1,896 | -33,452 |
| Income Tax | N/A | N/A | N/A | -5 | N/A |
| Net Income Continuous | -107,500 | -33,693 | -29,029 | 1,901 | -33,452 |
| Net Income | $-107,500 | $-33,693 | $-29,029 | $1,891 | $-33,452 |
| EPS Basic Total Ops | -23.60 | -11.00 | -22.20 | 1.80 | -35.20 |
| EPS Basic Continuous Ops | -23.64 | -10.91 | -22.24 | 1.80 | -35.23 |
| EPS Diluted Total Ops | -23.60 | -11.00 | -22.20 | 1.80 | -35.20 |
| EPS Diluted Continuous Ops | -23.64 | -10.91 | -22.24 | 1.75 | -35.23 |
| EPS Diluted Before Non-Recurring Items | -7.80 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-108,272 | $-34,292 | $-28,970 | $3,044 | $-34,830 |